In Newly Isolated Streptomyces Mangrovisoli Sp. Nov
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
341388717-Oa
ORIGINAL RESEARCH published: 16 May 2017 doi: 10.3389/fmicb.2017.00877 Streptomyces colonosanans sp. nov., A Novel Actinobacterium Isolated from Malaysia Mangrove Soil Exhibiting Antioxidative Activity and Cytotoxic Potential against Human Colon Cancer Cell Lines Jodi Woan-Fei Law 1, Hooi-Leng Ser 1, Acharaporn Duangjai 2, 3, Surasak Saokaew 1, 3, 4, Sarah I. Bukhari 5, Tahir M. Khan 1, 6, Nurul-Syakima Ab Mutalib 7, Kok-Gan Chan 8, Edited by: Bey-Hing Goh 1, 3* and Learn-Han Lee 1, 3* Dongsheng Zhou, Beijing Institute of Microbiology and 1 Novel Bacteria and Drug Discovery Research Group, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Epidemiology, China Malaysia, 2 Division of Physiology, School of Medical Sciences, University of Phayao, Phayao, Thailand, 3 Center of Health Reviewed by: Outcomes Research and Therapeutic Safety, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand, 4 Andrei A. Zimin, Faculty of Pharmaceutical Sciences, Pharmaceutical Outcomes Research Center, Naresuan University, Phitsanulok, 5 6 Institute of Biochemistry and Thailand, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia, Department of 7 Physiology of Microorganisms (RAS), Pharmacy, Absyn University Peshawar, Peshawar, Pakistan, UKM Medical Molecular Biology Institute, UKM Medical Centre, 8 Russia University Kebangsaan Malaysia, Kuala Lumpur, Malaysia, Division of Genetics and Molecular Biology, Faculty of Science, Antoine Danchin, Institute of Biological Sciences, University of Malaya, Kuala Lumpur, Malaysia Institut de Cardiométabolisme et Nutrition (ICAN), France Streptomyces colonosanans MUSC 93JT, a novel strain isolated from mangrove forest *Correspondence: Bey-Hing Goh soil located at Sarawak, Malaysia. The bacterium was noted to be Gram-positive and [email protected] to form light yellow aerial and vivid yellow substrate mycelium on ISP 2 agar. -
DAFTAR PUSTAKA Abidin, Z. A. Z., A. J. K. Chowdhury
160 DAFTAR PUSTAKA AKTINOMISETES PENGHASIL ANTIBIOTIK DARI HUTAN BAKAU TOROSIAJE GORONTALO YULIANA RETNOWATI, PROF. DR. A. ENDANG SUTARININGSIH SOETARTO, M.SC; PROF. DR. SUKARTI MOELJOPAWIRO, M.APP.SC; PROF. DR. TJUT SUGANDAWATY DJOHAN, M.SC Universitas Gadjah Mada, 2019 | Diunduh dari http://etd.repository.ugm.ac.id/ Abidin, Z. A. Z., A. J. K. Chowdhury, N. A. Malek, and Z. Zainuddin. 2018. Diversity, antimicrobial capabilities, and biosynthetic potential of mangrove actinomycetes from coastal waters in Pahang, Malaysia. J. Coast. Res., 82:174–179 Adegboye, M. F., and O. O. Babalola. 2012. Taxonomy and ecology of antibiotic producing actinomycetes. Afr. J. Agric. Res., 7(15):2255-2261 Adegboye, M.,F., and O. O. Babalola. 2013. Actinomycetes: a yet inexhausative source of bioactive secondary metabolites. Microbial pathogen and strategies for combating them: science, technology and eductaion, (A.Mendez-Vila, Ed.). Pp. 786 – 795. Adegboye, M. F., and O. O. Babalola. 2015. Evaluation of biosynthesis antibiotic potential of actinomycete isolates to produces antimicrobial agents. Br. Microbiol. Res. J., 7(5):243-254. Accoceberry, I., and T. Noel. 2006. Antifungal cellular target and mechanisms of resistance. Therapie., 61(3): 195-199. Abstract. Alongi, D. M. 2009. The energetics of mangrove forests. Springer, New Delhi. India Alongi, D. M. 2012. Carbon sequestration in mangrove forests. Carbon Management, 3(3):313-322 Amrita, K., J. Nitin, and C. S. Devi. 2012. Novel bioactive compounds from mangrove dirived Actinomycetes. Int. Res. J. Pharm., 3(2):25-29 Ara, I., M. A Bakir, W. N. Hozzein, and T. Kudo. 2013. Population, morphological and chemotaxonomical characterization of diverse rare actinomycetes in the mangrove and medicinal plant rhizozphere. -
Streptomyces As a Prominent Resource of Future Anti-MRSA Drugs
REVIEW published: 24 September 2018 doi: 10.3389/fmicb.2018.02221 Streptomyces as a Prominent Resource of Future Anti-MRSA Drugs Hefa Mangzira Kemung 1,2, Loh Teng-Hern Tan 1,2,3, Tahir Mehmood Khan 1,2,4, Kok-Gan Chan 5,6*, Priyia Pusparajah 3*, Bey-Hing Goh 1,2,7* and Learn-Han Lee 1,2,3,7* 1 Novel Bacteria and Drug Discovery Research Group, Biomedicine Research Advancement Centre, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia, 2 Biofunctional Molecule Exploratory Research Group, Biomedicine Research Advancement Centre, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia, 3 Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia, 4 The Institute of Pharmaceutical Sciences (IPS), University of Veterinary and Animal Sciences (UVAS), Lahore, Pakistan, 5 Division of Genetics and Molecular Biology, Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia, 6 International Genome Centre, Jiangsu University, Zhenjiang, China, 7 Center of Health Outcomes Research and Therapeutic Safety (Cohorts), School of Pharmaceutical Sciences, University of Phayao, Mueang Phayao, Thailand Methicillin-resistant Staphylococcus aureus (MRSA) pose a significant health threat as Edited by: they tend to cause severe infections in vulnerable populations and are difficult to treat Miklos Fuzi, due to a limited range of effective antibiotics and also their ability to form biofilm. These Semmelweis University, Hungary organisms were once limited to hospital acquired infections but are now widely present Reviewed by: Dipesh Dhakal, in the community and even in animals. Furthermore, these organisms are constantly Sun Moon University, South Korea evolving to develop resistance to more antibiotics. -
Anticancer Drug Discovery from Microbial Sources: the Unique Mangrove Streptomycetes
molecules Review Anticancer Drug Discovery from Microbial Sources: The Unique Mangrove Streptomycetes Jodi Woan-Fei Law 1, Lydia Ngiik-Shiew Law 2, Vengadesh Letchumanan 1 , Loh Teng-Hern Tan 1, Sunny Hei Wong 3, Kok-Gan Chan 4,5,* , Nurul-Syakima Ab Mutalib 6,* and Learn-Han Lee 1,* 1 Novel Bacteria and Drug Discovery (NBDD) Research Group, Microbiome and Bioresource Research Strength, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway 47500, Selangor Darul Ehsan, Malaysia; [email protected] (J.W.-F.L.); [email protected] (V.L.); [email protected] (L.T.-H.T.) 2 Monash Credentialed Pharmacy Clinical Educator, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville 3052, VIC, Australia; [email protected] 3 Li Ka Shing Institute of Health Sciences, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, China; [email protected] 4 Division of Genetics and Molecular Biology, Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur 50603, Malaysia 5 International Genome Centre, Jiangsu University, Zhenjiang 212013, China 6 UKM Medical Molecular Biology Institute (UMBI), UKM Medical Centre, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia * Correspondence: [email protected] (K.-G.C.); [email protected] (N.-S.A.M.); [email protected] (L.-H.L.) Academic Editor: Owen M. McDougal Received: 8 October 2020; Accepted: 13 November 2020; Published: 17 November 2020 Abstract: Worldwide cancer incidence and mortality have always been a concern to the community. The cancer mortality rate has generally declined over the years; however, there is still an increased mortality rate in poorer countries that receives considerable attention from healthcare professionals. -
Actinobacteria and Myxobacteria Isolated from Freshwater Snails and Other Uncommon Iranian Habitats, Their Taxonomy and Secondary Metabolism
Actinobacteria and Myxobacteria isolated from freshwater snails and other uncommon Iranian habitats, their taxonomy and secondary metabolism Von der Fakultät für Lebenswissenschaften der Technischen Universität Carolo-Wilhelmina zu Braunschweig zur Erlangung des Grades einer Doktorin der Naturwissenschaften (Dr. rer. nat.) genehmigte D i s s e r t a t i o n von Nasim Safaei aus Teheran / Iran 1. Referent: Professor Dr. Michael Steinert 2. Referent: Privatdozent Dr. Joachim M. Wink eingereicht am: 24.02.2021 mündliche Prüfung (Disputation) am: 20.04.2021 Druckjahr 2021 Vorveröffentlichungen der Dissertation Teilergebnisse aus dieser Arbeit wurden mit Genehmigung der Fakultät für Lebenswissenschaften, vertreten durch den Mentor der Arbeit, in folgenden Beiträgen vorab veröffentlicht: Publikationen Safaei, N. Mast, Y. Steinert, M. Huber, K. Bunk, B. Wink, J. (2020). Angucycline-like aromatic polyketide from a novel Streptomyces species reveals freshwater snail Physa acuta as underexplored reservoir for antibiotic-producing actinomycetes. J Antibiotics. DOI: 10.3390/ antibiotics10010022 Safaei, N. Nouioui, I. Mast, Y. Zaburannyi, N. Rohde, M. Schumann, P. Müller, R. Wink.J (2021) Kibdelosporangium persicum sp. nov., a new member of the Actinomycetes from a hot desert in Iran. Int J Syst Evol Microbiol (IJSEM). DOI: 10.1099/ijsem.0.004625 Tagungsbeiträge Actinobacteria and myxobacteria isolated from freshwater snails (Talk in 11th Annual Retreat, HZI, 2020) Posterbeiträge Myxobacteria and Actinomycetes isolated from freshwater snails and -
The Rising of “Modern Actinobacteria” Era Jodi Woan-Fei Law1, Vengadesh Letchumanan1, Loh Teng-Hern Tan1, Hooi-Leng Ser1, Bey-Hing Goh2, Learn-Han Lee1*
Review Article Progress in Microbes and Molecular Biology The Rising of “Modern Actinobacteria” Era Jodi Woan-Fei Law1, Vengadesh Letchumanan1, Loh Teng-Hern Tan1, Hooi-Leng Ser1, Bey-Hing Goh2, Learn-Han Lee1* 1Novel Bacteria and Drug Discovery Research Group (NBDD), Microbiome and Bioresource Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, 47500 Bandar Sunway, Selangor Darul Ehsan, Malaysia. 2Biofunctional Molecule Exploratory Research Group (BMEX), School of Pharmacy, Monash University Malaysia, 47500 Bandar Sunway, Selangor Darul Ehsan, Malaysia. Abstract: The term “Modern Actinobacteria” (MOD-ACTINO) was coined by a Malaysian Scientist Dr. Lee Learn-Han, who has great expertise and experience in the field of actinobacteria research. MOD-ACTINO is defined as a group of actinobacteria capable of producing compounds that can be explored for modern applications such as development of new drugs and cosmeceutics. MOD-ACTINO members consist of already identified or novel actinobacteria isolated from special environments: mangrove, desert, lake, hot spring, cave, mountain, Arctic and Antarctic regions. These actinobac- teria are valuable sources for various industries which can contribute directly/indirectly towards the improvement in many aspects of our lives. Keywords: modern; bioactive; actinobacteria; *Correspondence: Learn-Han Lee, Novel Bacteria and environment; bioprospecting Drug Discovery Research Group (NBDD), Microbiome and Biore-source Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences, Monash Uni- Received: 16th February 2020 versity Malaysia, 47500 Bandar Sunway, Selangor Darul Accepted: 23rd March 2020 Ehsan, Malaysia. lee. [email protected] Published Online: 29th March 2020 Citation: Law JW-F, Letchumanan V, Tan LT-H et al. -
Genomic and Phylogenomic Insights Into the Family Streptomycetaceae Lead to Proposal of Charcoactinosporaceae Fam. Nov. and 8 No
bioRxiv preprint doi: https://doi.org/10.1101/2020.07.08.193797; this version posted July 8, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Genomic and phylogenomic insights into the family Streptomycetaceae 2 lead to proposal of Charcoactinosporaceae fam. nov. and 8 novel genera 3 with emended descriptions of Streptomyces calvus 4 Munusamy Madhaiyan1, †, * Venkatakrishnan Sivaraj Saravanan2, † Wah-Seng See-Too3, † 5 1Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, 6 Singapore 117604; 2Department of Microbiology, Indira Gandhi College of Arts and Science, 7 Kathirkamam 605009, Pondicherry, India; 3Division of Genetics and Molecular Biology, 8 Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, 9 Malaysia 10 *Corresponding author: Temasek Life Sciences Laboratory, 1 Research Link, National 11 University of Singapore, Singapore 117604; E-mail: [email protected] 12 †All these authors have contributed equally to this work 13 Abstract 14 Streptomycetaceae is one of the oldest families within phylum Actinobacteria and it is large and 15 diverse in terms of number of described taxa. The members of the family are known for their 16 ability to produce medically important secondary metabolites and antibiotics. In this study, 17 strains showing low 16S rRNA gene similarity (<97.3 %) with other members of 18 Streptomycetaceae were identified and subjected to phylogenomic analysis using 33 orthologous 19 gene clusters (OGC) for accurate taxonomic reassignment resulted in identification of eight 20 distinct and deeply branching clades, further average amino acid identity (AAI) analysis showed 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.08.193797; this version posted July 8, 2020. -
Marine Rare Actinomycetes: a Promising Source of Structurally Diverse and Unique Novel Natural Products
Review Marine Rare Actinomycetes: A Promising Source of Structurally Diverse and Unique Novel Natural Products Ramesh Subramani 1 and Detmer Sipkema 2,* 1 School of Biological and Chemical Sciences, Faculty of Science, Technology & Environment, The University of the South Pacific, Laucala Campus, Private Mail Bag, Suva, Republic of Fiji; [email protected] 2 Laboratory of Microbiology, Wageningen University & Research, Stippeneng 4, 6708 WE Wageningen, The Netherlands * Correspondence: [email protected]; Tel.: +31-317-483113 Received: 7 March 2019; Accepted: 23 April 2019; Published: 26 April 2019 Abstract: Rare actinomycetes are prolific in the marine environment; however, knowledge about their diversity, distribution and biochemistry is limited. Marine rare actinomycetes represent a rather untapped source of chemically diverse secondary metabolites and novel bioactive compounds. In this review, we aim to summarize the present knowledge on the isolation, diversity, distribution and natural product discovery of marine rare actinomycetes reported from mid-2013 to 2017. A total of 97 new species, representing 9 novel genera and belonging to 27 families of marine rare actinomycetes have been reported, with the highest numbers of novel isolates from the families Pseudonocardiaceae, Demequinaceae, Micromonosporaceae and Nocardioidaceae. Additionally, this study reviewed 167 new bioactive compounds produced by 58 different rare actinomycete species representing 24 genera. Most of the compounds produced by the marine rare actinomycetes present antibacterial, antifungal, antiparasitic, anticancer or antimalarial activities. The highest numbers of natural products were derived from the genera Nocardiopsis, Micromonospora, Salinispora and Pseudonocardia. Members of the genus Micromonospora were revealed to be the richest source of chemically diverse and unique bioactive natural products. -
Polyphasic Systematics of Marine Bacteria and Their Alpha-Glucosidase Inhibitor Activity
Polyphasic systematics of marine bacteria and their alpha-glucosidase inhibitor activity Thesis Submitted to AcSIR For the Award of the Degree of DOCTOR OF PHILOSOPHY In Biological Science By RAHUL BHOLESHANKAR MAWLANKAR AcSIR no. 10BB13J26036 Under the guidance of Research Supervisor Dr. Syed G. Dastager Research Co-supervisor Dr. Mahesh S. Dharne NCIM Resource Centre, Biochemical Science divison, CSIR-National Chemical Laboratory, Pune-411 008, India Table of contents Table of contents 1 Certificate 4 Declaration 5 Acknowledgment 6 List of fugures 9 List of tables 12 List of abbreviations 14 Abstract 16 Chapter 1. Introduction 19 1.1. Bacterial Systematics 20 1.1.1. Phenotypic analysis 22 1.1.2. Phylogenetic analysis 28 1.1.2.1. The 16S rRNA gene sequencing 29 1.1.2.2. Phylogenetic analysis 30 1.1.2.3. Whole genome analysis 32 1.1.3. Genotypic analysis 33 1.1.3.1. DNA-DNA hybridization (DDH) 33 1.1.3.2. Genomic DNA G+C content 35 1.1.3.3. Multi-locus sequence typing (MLST) 36 1.1.3.4. DNA profiling 37 1.2. Marine bacteria and their potentials 38 1.3. Marine sediments 39 1.4. Alpha-glucosidase inhibitor 44 1.4.1. Acarbose 45 1.4.2. Voglibose 48 1.4.3. Nojirimycin 49 1.4.4. 1-deoxynojirimycin 50 1.4.5. Miglitol 51 1.5. Alpha-glucosidase inhibitors from marine isolates 52 Chapter 2. Polyphasic Systematic approach 55 2.1. Overview 56 2.2. Isolation of marine sediment sample 57 2.3. Characterization 57 2.3.1. -
Streptomyces Monashensis Sp. Nov., a Novel Mangrove Soil
www.nature.com/scientificreports Corrected: Author Correction OPEN Streptomyces monashensis sp. nov., a novel mangrove soil actinobacterium from East Received: 13 September 2018 Accepted: 21 January 2019 Malaysia with antioxidative Published online: 28 February 2019 potential Jodi Woan-Fei Law1, Hooi-Leng Ser1,2,3, Nurul-Syakima Ab Mutalib 4, Surasak Saokaew 1,5,6, Acharaporn Duangjai1,5,7, Tahir Mehmood Khan2,8, Kok-Gan Chan 9,10, Bey-Hing Goh2,3,5 & Learn-Han Lee1,3,5 A new Streptomyces species discovered from Sarawak mangrove soil is described, with the proposed name – Streptomyces monashensis sp. nov. (strain MUSC 1JT). Taxonomy status of MUSC 1JT was determined via polyphasic approach. Phylogenetic and chemotaxonomic properties of strain MUSC 1JT were in accordance with those known for genus Streptomyces. Based on phylogenetic analyses, the strains closely related to MUSC 1JT were Streptomyces corchorusii DSM 40340T (98.7%), Streptomyces olivaceoviridis NBRC 13066T (98.7%), Streptomyces canarius NBRC 13431T (98.6%) and Streptomyces coacervatus AS-0823T (98.4%). Outcomes of DNA–DNA relatedness between strain MUSC 1JT and its closely related type strains covered from 19.7 ± 2.8% to 49.1 ± 4.3%. Strain MUSC 1JT has genome size of 10,254,857 bp with DNA G + C content of 71 mol%. MUSC 1JT extract exhibited strong antioxidative activity up to 83.80 ± 4.80% in the SOD assay, with signifcant cytotoxic efect against colon cancer cell lines HCT-116 and SW480. Streptomyces monashensis MUSC 1JT (=DSM 103626T = MCCC 1K03219T) could potentially be a producer of novel bioactive metabolites; hence discovery of this new species may be highly signifcant to the biopharmaceutical industry as it could lead to development of new and useful chemo-preventive drugs. -
The Roles of Streptomyces and Novel Species Discovery
Review Article Progress in Microbes and Molecular Biology A Review on Mangrove Actinobacterial Diversity: The Roles of Streptomyces and Novel Species Discovery Jodi Woan-Fei Law1,2, Priyia Pusparajah1, Nurul-Syakima Ab Mutalib3, Sunny Hei Wong4, Bey-Hing Goh5*, Learn-Han Lee1* 1Novel Bacteria and Drug Discovery Research Group, Microbiome and Bioresource Research Strength, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Selangor Darul Ehsan, Malaysia 2Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, PR China 3UKM Medical Molecular Biology Institute (UMBI), UKM Medical Centre, University Kebangsaan Malaysia, Kuala Lum- pur, Malaysia 4Li Ka Shing Institute of Health Sciences, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong 5Biofunctional Molecule Exploratory Research Group (BMEX), School of Pharmacy, Monash University Malaysia, Selangor Darul Ehsan, Malaysia Abstract : In the class Actinobacteria, the renowned genus Streptomyces comprised of a group of uniquely complex bacteria that capable of synthesizing a great variety of bioactive metabolites. Streptomycetes are noted to possess several special qual- ities such as multicellular life cycle and large linearized chromosomes. The significant contribution of Streptomyces in mi- crobial drug discovery as witnessed through the discovery of many important antibiotic drugs has undeniably encourage the exploration of these bacteria from different environments, especially the mangrove environments. This review emphasizes on the genus Streptomyces and reports on the diversity of actinobacterial population from mangroves at different regions of the world as well as discovery of mangrove-derived novel Streptomyces species. Overall, the research on diversity of Actinobac- teria in the mangrove environments remains limited. -
Evaluation of Antioxidative and Cytotoxic Activities of Streptomyces Pluripotens MUSC 137 Isolated from Mangrove Soil in Malaysia
ORIGINAL RESEARCH published: 16 December 2015 doi: 10.3389/fmicb.2015.01398 Evaluation of Antioxidative and Cytotoxic Activities of Streptomyces pluripotens MUSC 137 Isolated from Mangrove Soil in Malaysia Hooi-Leng Ser1, Nurul-Syakima Ab Mutalib2, Wai-Fong Yin3, Kok-Gan Chan3, Bey-Hing Goh1* and Learn-Han Lee1* 1 Biomedical Research Laboratory, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia, 2 UKM Medical Molecular Biology Institute–UKM Medical Centre, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia, 3 Division of Genetics and Molecular Biology, Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia Streptomyces pluripotens MUSC 137 was isolated from mangrove soil obtained from Tanjung Lumpur, Pahang, Malaysia. We investigated the phylogenetic, genomic, biochemical, and phenotypic characteristics of this strain. Uniquely adapted Edited by: microorganisms from mangrove habitats have previously yielded compounds of Dongsheng Zhou, biopharmaceutical interest. In order to examine the bioactivities possessed by the Beijing Institute of Microbiology strain, fermentation extract was prepared through solvent extraction method prior and Epidemiology, China Reviewed by: to bioactivities screenings. Antioxidant activity was examined via DPPH assay while Jyl Matson, the cytotoxic effect was assessed by means of examining the activity of the extract University of Toledo, USA against selected human cancer cell lines, namely colon cancer cells (HCT-116, Caco- Lorenzo Giacani, University of Washington, USA 2, SW480, and HT-29), breast cancer cell (MCF-7), lung cancer cell (A549), prostate *Correspondence: cancer cell (DU145), and cervical cancer cell (Ca Ski). The results revealed MUSC Learn-Han Lee 137 possesses significant antioxidant activity and demonstrates cytotoxic effect against [email protected]; several cancer cell lines tested.